alka-seltzer original

Generic: anhydrous citric acid, aspirin, and sodium bicarbonate

Labeler: r j general corporation
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name alka-seltzer original
Generic Name anhydrous citric acid, aspirin, and sodium bicarbonate
Labeler r j general corporation
Dosage Form TABLET, EFFERVESCENT
Routes
ORAL
Active Ingredients

anhydrous citric acid 1000 mg/1, aspirin 325 mg/1, sodium bicarbonate 1916 mg/1

Manufacturer
R J General Corporation

Identifiers & Regulatory

Product NDC 70264-014
Product ID 70264-014_43c89573-4cf2-997f-e063-6394a90a76ca
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 2010-03-02

Pharmacologic Class

Established (EPC)
calculi dissolution agent [epc] anti-coagulant [epc] nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
acidifying activity [moa] calcium chelating activity [moa] cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased coagulation factor activity [pe] decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70264014
Hyphenated Format 70264-014

Supplemental Identifiers

RxCUI
1536675 1536680
UPC
0026431297031
UNII
XF417D3PSL R16CO5Y76E 8MDF5V39QO
NUI
N0000175833 N0000175835 N0000175980 N0000008556 N0000175089 N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name alka-seltzer original (source: ndc)
Generic Name anhydrous citric acid, aspirin, and sodium bicarbonate (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1000 mg/1
  • 325 mg/1
  • 1916 mg/1
source: ndc
Packaging
  • 50 POUCH in 1 CARTON (70264-014-01) / 2 TABLET, EFFERVESCENT in 1 POUCH
source: ndc

Packages (1)

70264-014-01 50 POUCH in 1 CARTON (70264-014-01) / 2 TABLET, EFFERVESCENT in 1 POUCH

Ingredients (3)

anhydrous citric acid (1000 mg/1) aspirin (325 mg/1) sodium bicarbonate (1916 mg/1)

Linked Drug Pages (1)

Alka-Seltzer Original ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "43c89573-4cf2-997f-e063-6394a90a76ca", "openfda": {"nui": ["N0000175833", "N0000175835", "N0000175980", "N0000008556", "N0000175089", "N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0026431297031"], "unii": ["XF417D3PSL", "R16CO5Y76E", "8MDF5V39QO"], "rxcui": ["1536675", "1536680"], "spl_set_id": ["dbb0d067-71f0-45e4-bc98-548cf4a90b3a"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Coagulation Factor Activity [PE]", "Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Calculi Dissolution Agent [EPC]", "Anti-coagulant [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Acidifying Activity [MoA]", "Calcium Chelating Activity [MoA]", "Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["R J General Corporation"]}, "finished": true, "packaging": [{"sample": false, "description": "50 POUCH in 1 CARTON (70264-014-01)  / 2 TABLET, EFFERVESCENT in 1 POUCH", "package_ndc": "70264-014-01", "marketing_start_date": "20100302"}], "brand_name": "Alka-Seltzer Original", "product_id": "70264-014_43c89573-4cf2-997f-e063-6394a90a76ca", "dosage_form": "TABLET, EFFERVESCENT", "pharm_class": ["Acidifying Activity [MoA]", "Alkalinizing Activity [MoA]", "Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Anti-coagulant [EPC]", "Calcium Chelating Activity [MoA]", "Calculi Dissolution Agent [EPC]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Coagulation Factor Activity [PE]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "70264-014", "generic_name": "ANHYDROUS CITRIC ACID, ASPIRIN, and SODIUM BICARBONATE", "labeler_name": "R J General Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Alka-Seltzer Original", "active_ingredients": [{"name": "ANHYDROUS CITRIC ACID", "strength": "1000 mg/1"}, {"name": "ASPIRIN", "strength": "325 mg/1"}, {"name": "SODIUM BICARBONATE", "strength": "1916 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20100302", "listing_expiration_date": "20261231"}